Article

Usefulness of magnetic resonance imaging for the diagnosis of right ventricular dysplasia in children.

Division of Cardiology, Department of Pediatrics, The Children's Hospital of Philadelphia, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
The American Journal of Cardiology (Impact Factor: 3.43). 05/2006; 97(8):1232-7. DOI: 10.1016/j.amjcard.2005.11.045
Source: PubMed

ABSTRACT Cardiac magnetic resonance (CMR) has been helpful in adults in the diagnosis of arrhythmogenic right ventricular dysplasia. Short of direct surgical observation or autopsy, no gold standard exists. CMR diagnostic criteria include right atrial and ventricular dilation, regional right ventricular (RV) wall motion abnormalities, outflow tract ectasia, and myocardial fatty infiltration. To determine whether adult diagnostic criteria are useful in children referred for CMR for this diagnosis, the images and records of 81 patients (aged 11.5 +/- 5.5 years) over an 8-year period were reviewed. Histories included ventricular tachycardia, palpitations, dilated right ventricle, syncope, near sudden death, or family history of RV dysplasia. Four families were studied with parents who had RV dysplasia diagnosed by surgery, explanted heart, or CMR. CMR imaging included T1-weighted imaging, cine, 1-dimensional RV myocardial tagging, and phase-encoded velocity mapping, and 2 patients underwent delayed-enhancement CMR. Only 1 of the 81 patients met 5 of the criteria. None of the others met >2 of the criteria, and only 2 patients met 1 or 2 criteria. For questionable regional wall motion abnormalities, RV myocardial tagging was helpful. In conclusion, CMR of patients with a history suspicious for the diagnosis of RV dysplasia is a low-yield test in children. This may be due to the evolving nature of the disease, which does not manifest itself from a morphologic or ventricular-function standpoint until later in development. Follow-up studies as patients age may be advantageous.

0 Bookmarks
 · 
47 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Arrhythmogenic right ventricular dysplasia/cardiomyopathy is a congenital disease that may present with sudden cardiac death as the first manifestation. Standards for the difficult clinical diagnosis are the so-called modified Task Force criteria that incorporate imaging-based, electrocardiographic and anamnestic information. Cardiac magnetic resonance imaging (MRI) is the standard technique for imaging of the right ventricle and can compliment the recent ARVD/C diagnosis criteria by providing exact information on right ventricular size and function. It is the most reliable modality available for the detection of right ventricular aneurysms and the quantification of ventricular size. Furthermore, MRI is able to identify areas of fatty or fibrous replacement within the right ventricular myocardium in a non-invasive way. However, a suspicion of ARVD/C cannot be confirmed or excluded based on MRI findings alone. In clinical routine cardiac MRI is an enormously important component in the ARVD/C diagnostic toolbox; however, MRI can only act as one part of the diagnostic puzzle and should exclusively be performed by experienced centers using specifically tailored protocols.
    Der Radiologe 01/2013; 53(1):38-44. · 0.41 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Die arrhythmogene rechtsventrikuläre Dysplasie/Kardiomyopathie (ARVD/C) ist eine angeborene Erkrankung, deren Erstmanifestation häufig der plötzliche Herztod ist. Standard für die schwierige Diagnostik sind die sog. modifizierten Task-force-Kriterien, in die bildgebende, elektrokardiographische und anamnestische Befunde eingehen. Die MRT ist das Standardverfahren zur Darstellung des rechten Ventrikels. Zu den derzeit gültigen ARVD/C-Diagnosekriterien kann die MRT exakte Informationen zu Größe und Funktion des rechten Ventrikels liefern. Für die Identifizierung rechtsventrikulärer Aneurysmata und zur Quantifizierung der Ventrikelgröße ist die MRT die zuverlässigste verfügbare Methode. Darüber hinaus können Fibrose- und Fettareale innerhalb des rechtsventrikulären Myokards nichtinvasiv nachgewiesen werden. Jedoch kann eine ARVD/C aufgrund MR-tomographischer Befunde alleine weder bewiesen noch ausgeschlossen werden. In der Praxis der ARVD/C-Diagnostik ist die MRT eine enorm wichtige Komponente. Sie kann jedoch nur als ein Baustein unter mehreren fungieren und sollte nur mit speziell abgestimmten Protokollen und von erfahrenen Zentren angewendet werden.
    Der Radiologe 01/2013; 53(1). · 0.41 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Signal averaged electrocardiogram (SAECG) is a specific and non-invasive tool useful for arrhythmogenic right ventricular cardiomyopathy (ARVC) diagnosis. However, its role in risk stratification of patients with ARVC remains largely undefined. Sixty-four patients fulfilling Task Force ARVC criteria (mean age: 47±14years-old, 56% male, 50% definite ARVC) were enrolled. The baseline demographic, electrocardiographic, structural, and electrophysiological characteristics were collected. Patients with SAECG fulfilling all 3 Task Force criteria (3+ SAECG) were categorized into group 1, and those fulfilled 2 or less criterion were categorized into group 2. The study endpoints were unstable ventricular arrhythmia (VA), device detectable sustained fast VA (cycle lengths <240ms) and cardiovascular death. During a mean follow-up of 21±20months, 15 primary endpoints including 12 unstable VAs and 3 device-detected fast VAs were met. One patient died of electrical storm, and one patient underwent heart transplantation. The presence of 3+ SAECG predicted malignant events in all patients with definite and non-definite ARVC (p<0.01, OR=30.5, 95% CI=2.5-373.7) and in patients with definite ARVC alone (p=0.03, OR=11.1, 95% CI=1.3-93.9). Patients diagnosed with non-definite ARVC without 3+ SAECG were free from malignant events. SAECG fulfilling all 3 Task Force criteria was an independent risk predictor of malignant events in ARVC patients. SAECG may play a valuable role in ARVC risk stratification.
    International journal of cardiology 04/2014; · 6.18 Impact Factor